MarketInOut Stock Screener Log In | Sign Up
 

Dare Bioscience Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Dare Bioscience Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization12.82 mln
Float17.22 mln
Earnings Date11/05/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

18.58
Highly suspicious

Relative Strength

16 / 100
Significantly lagging

Pre-Tax Margin

-804%
Severely loss-making

ROE

-748
Deeply negative

Altman Z-Score

-13.22
Deeply distressed

Business Description

Daré Bioscience Inc. is a San Diego-based company founded in 2015 that focuses on developing medical treatments for women's health, including contraception, fertility, menopause, pelvic pain, and vaginal and sexual health. Its marketed product, XACIATO, is an antibacterial gel used to treat bacterial vaginosis, while its broad pipeline includes hormone-free contraceptives, pain relief treatments, menopause therapies, and solutions for HPV-related conditions. The company also pursues innovations in preterm birth prevention, fertility support, and non-hormonal contraception for both men and women.

Key Fundamentals

EPS-0.71
ROE-748
RPS0.10
ROIC-47.00
ROA-43.46
Interest Cover-55.72
EBITDA, mln-7.64
EV / EBITDA-1.35
EV / EBIT-1.02
Revenue, mln1.37
EV / Revenue7.57

Quote Details

Last 0.6459
Change -0.0058 (-0.89%)
Open 0.64
Volume 56,343
Turnover 36,392
Average Volume 186,126

Financial Ratios

Pre-Tax Profit Margin-804
Current Ratio0.99
Price / Sales9.07

Financial Strength

Altman Z-Score-13.22
Piotroski F-Score 4 / 9
Beneish M-Score18.58
Short Ratio3.03
Short % of Float4.71

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.86% 8 / 100   
1 Month -12.78% 26 / 100   
2 Months -51.8% 8 / 100   
6 Months -69.39% 7 / 100   
1 Year -68.8% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog